St. Louis, MO, United States of America

Vishnu Damalanka

This inventor holds 2 USPTO granted patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Washington University. Active years: 2023-2026.


% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vishnu Damalanka: Innovator in Bacterial Infection Treatment

Introduction

Vishnu Damalanka is an accomplished inventor based in St. Louis, MO (US). He has made significant contributions to the field of medical science, particularly in the treatment of bacterial infections. His innovative work has the potential to improve patient outcomes and advance healthcare solutions.

Latest Patents

Vishnu holds 1 patent for his invention titled "Compounds and methods for treating bacterial infections." This patent focuses on various compounds, compositions, and methods aimed at treating bacterial infections, including urinary tract infections. His research addresses a critical need in the medical community for effective treatment options.

Career Highlights

Vishnu is affiliated with Washington University, where he engages in research and development related to his patent. His work at this prestigious institution allows him to collaborate with other experts in the field and contribute to groundbreaking advancements in medical treatments.

Collaborations

Vishnu has worked alongside notable colleagues, including Vasilios Kalas and James Walter Janetka. These collaborations enhance the research environment and foster innovation in the development of new therapeutic methods.

Conclusion

Vishnu Damalanka's contributions to the treatment of bacterial infections exemplify the impact of innovative thinking in healthcare. His work not only addresses pressing medical challenges but also paves the way for future advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…